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Abstract
 
Leukocyte rolling in postcapillary venules of inflamed tissues is reduced in L-selectin–deficient
mice and mice treated with L-selectin blocking antibodies, but the glycoprotein ligand for
L-selectin in inflamed venules is unknown. Here, we show that L-selectin–dependent rolling
after P-selectin blockade is completely absent in P-selectin glycoprotein ligand-1 (PSGL-1)
 
 
 
/
 
 
 
mice or wild-type mice treated with a PSGL-1 blocking monoclonal antibody. Immunohis-
tochemistry and flow cytometry failed to show PSGL-1 expression on resting or inflamed en-
dothelium or on platelets. To investigate whether leukocyte-expressed PSGL-1 is mediating
L-selectin–dependent rolling, we reconstituted lethally irradiated wild-type mice with PSGL-
1
 
 
 
/
 
 
 
 bone marrow cells. These chimeric mice showed no L-selectin–dependent rolling, sug-
gesting that leukocyte-expressed PSGL-1 mediates L-selectin–dependent rolling. Frame-
to-frame video analysis of L-selectin–dependent rolling in wild-type mice showed that the
majority of observed L-selectin–dependent leukocyte rolling was between free flowing leuko-
cytes and already adherent leukocytes or possibly leukocyte fragments, followed by E-selectin–
dependent leukocyte rolling along the endothelium. Leukocyte rolling was significantly slower
for leukocyte–endothelial than leukocyte–leukocyte interactions. We conclude that leukocyte-
expressed PSGL-1 serves as the main L-selectin ligand in inflamed postcapillary venules. L-selec-
tin binding to PSGL-1 initiates tethering events that enable L-selectin–independent leukocyte-
endothelial interactions. These findings provide a molecular mechanism for the inflammatory
defects seen in L-selectin–deficient mice.
Key words: PSGL-1 • L-selectin • inﬂammation • leukocyte rolling • intravital
 
Introduction
 
Leukocyte recruitment to sites of inflammation follows a
multistep process (1) beginning with the initial capture of
leukocytes to the vessel wall and leukocyte rolling along
the endothelial layer. During rolling leukocytes gradually
become activated (2), which eventually leads to firm adhe-
sion and transmigration. Leukocyte capture and rolling, the
initial steps of leukocyte recruitment, require the selectin
family of adhesion molecules to bind to their counterrecep-
tors or selectin ligands (3, 4). L-selectin is constitutively ex-
pressed on most leukocytes and serves as a lymphocyte
homing receptor with well-defined L-selectin ligands ex-
pressed on high endothelial venules (5).
L-selectin is also involved in the recruitment of leuko-
cytes into sites of inflammation. This was originally shown
as a reduction of leukocyte migration into inflamed skin in
mice treated with the L-selectin blocking mAb MEL-14
(6) and confirmed by in vivo studies using mice deficient in
L-selectin showing a significant reduction in the number of
leukocytes recruited into inflamed peritoneum 24 to 48 h
after intraperitoneal injection of thioglycollate (7). Leuko-
cyte rolling in cremaster muscle venules of L-selectin–defi-
 
This online version of this article contains supplemental material.
M. Sperandio’s present address is Neonatal Unit, Children’s Hospital,
University of Heidelberg, Heidelberg 69120, Germany.
Address correspondence to Klaus Ley, University of Virginia Health
System, Cardiovascular Research Center, MR5 Bldg, Rm. 1013, P.O.
Box 801 394, Charlottesville, VA 22908-1394. Phone: 434-243-9966;
Fax: 434-982-3870; E-mail: klausley@virginia.eduT
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
 
1356
 
L-Selectin Ligand in Inflamed Venules
 
cient mice or mice treated with a function blocking mAb
against L-selectin was significantly decreased at 1 h or later
after exteriorization of the cremaster muscle (8) or after
prolonged stimulation with TNF-
 
 
 
 (9) but not in freshly
exteriorized venules (8). These findings suggested the exist-
ence of inducible endothelial ligand(s) for L-selectin.
In vitro studies on TNF-
 
 
 
 stimulated human umbilical
vein endothelial cells (HUVECs)
 
*
 
 incubated with isolated
leukocytes in a rotating assay showed that blocking of L-selec-
tin led to a 50% reduction in leukocyte adhesion to the
HUVEC monolayer (10). However, this study did not ad-
dress if the reduction in leukocyte adhesion was due to a
decrease in leukocyte rolling preceding the firm arrest of
leukocytes. Bargatze et al. showed that rolling of isolated
human neutrophils on HUVECs stimulated with IL-1 for
4 h was blocked by mAbs against L-selectin (11). Interest-
ingly, a significant portion of neutrophils rolled on already
adherent neutrophils and this rolling was mediated via
L-selectin on the rolling cells (11). Alon et al. later intro-
duced the term ‘secondary tethering’ for this phenomenon
and demonstrated that human neutrophils perfused on P-
or E-selectin accumulated significantly faster in the pres-
ence of L-selectin-dependent leukocyte–leukocyte interac-
tions (12). These interleukocyte tethering events led to the
characteristic formation of strings not observed after treat-
ment with an L-selectin blocking mAb. However, such
strings are not observed in vivo, and initial studies in TNF-
 
 
 
–treated postcapillary venules failed to identify secondary
tethering as an important mechanism (13). In larger vessels
with diameters 
 
 
 
45 
 
 
 
m, but not in smaller venules (diam-
eters 
 
 
 
45 
 
 
 
m), the L-selectin blocking mAb MEL-14 sig-
nificantly reduced leukocyte rolling (14), suggesting sec-
ondary tethering events.
Several studies identified the homodimeric sialomucin
P-selectin glycoprotein ligand-1 (PSGL-1) as an L-selectin
ligand mediating leukocyte–leukocyte interactions in vitro
(15, 16). In contrast, L-selectin ligands mediating leuko-
cyte capture and rolling in inflamed or cytokine-activated
venules could only be identified at a functional but not at a
molecular level (5, 8, 9). Studies on human microvascular
endothelial cells stimulated with TNF-
 
 
 
 suggested that
L-selectin–dependent leukocyte rolling required sulfated
L-selectin ligands (17, 18). In mice deficient in core2 
 
 
 
1,6
N-acetyl glucosaminyltransferase I (19), a key enzyme in
the posttranslational glycosylation of functional selectin
ligands, L-selectin ligand activity was completely lost on
inflamed postcapillary venules of the cremaster muscle
while L-selectin ligand activity was unchanged in Peyer’s
patch high endothelial venules (20). In addition, fucosyla-
tion-dependent epitopes such as HECA452 have been
identified on putative L-selectin ligands expressed on fuco-
syltransferase-VII transfected human vascular endothelial
cells (18), suggesting a contribution of 
 
 
 
1,3 linked fucose
to L-selectin ligand activity on inflamed endothelium. Cu-
mulatively, these functional data provided strong evidence
 
for the existence of an inducible L-selectin ligand on in-
flamed endothelium exhibiting glycosylation requirements
typical of selectin ligands.
The present study was undertaken to find ligand glyco-
proteins relevant for L-selectin–dependent rolling on in-
flamed venular endothelium. To this end, we investigated
leukocyte rolling in unstimulated and TNF-
 
 
 
–treated cre-
master muscle venules under conditions of isolated L-selec-
tin-mediated rolling (8) achieved by blocking P- and
E-selectin function. Unexpectedly, we found a complete
absence of L-selectin–dependent leukocyte rolling in
PSGL-1–deficient mice.
 
Materials and Methods
 
Animals.
 
Mice lacking a functional gene encoding PSGL-1
were generated as described earlier (21) and maintained as a het-
erozygous breeding colony at the University of Virginia. The
wild-type PSGL-1 allele was detected using PCR primers PC-I
(5
 
 
 
-CCA TAT CTC TGC TCC TGT CTC-3
 
 
 
) and PC-II
(5
 
 
 
-TAC AGC CTG AAT CCT GGG AAG CTG-3
 
 
 
) located
adjacent to the deleted region, while the inserted 
 
Neo
 
-gene of
the mutant allele was detected using PKO-1 (5
 
 
 
 CTT TTT GTC
AAG ACC GAC CTG TC 3
 
 
 
) and PKO-2 (5
 
 
 
 AGA TCA TCC
TGA TCG ACA AGA CC 3
 
 
 
). Heterozygous (
 
 
 
/
 
 
 
) and ho-
mozygous (
 
 
 
/
 
 
 
) littermates were used for control experiments.
All PSGL-1
 
 
 
/
 
 
 
 mice and wild-type mice used in this study were
at least 8 wk of age and appeared healthy. Mice were housed in a
barrier facility under SPF conditions. All animal experiments
were approved by the Institutional Animal Care and Use Com-
mittee.
 
Antibodies and Cytokines.
 
Monoclonal blocking antibodies
RB40.34 (rat IgG1, 30 
 
 
 
g/mouse; reference 22) against P-selec-
tin and 4RA10 (rat IgG1, 30 
 
 
 
g/mouse; reference 23) against
PSGL-1 were provided by Dr. D. Vestweber, University of
Münster, Münster, Germany. E-selectin blocking mAb 9A9 (rat
IgG1, 30 
 
 
 
g/mouse; reference 24) blocks E-selectin–dependent
rolling in vivo and in vitro and was provided by Dr. B. Wolitzky
(Hoffmann-La Roche, Inc., Nutley, NJ). The rat anti–mouse
L-selectin blocking mAb MEL-14 (rat IgG2a; reference 25) and
CD18 mAb GAME-46 were purified from hybridoma superna-
tant (American Type Culture Collection). MEL-14 was pro-
cessed to F(ab
 
 
 
)
 
2
 
-fragments (Pierce Immunoglobulin F(ab
 
 
 
)
 
2
 
Preparation Kit; Pierce Chemical Co.). In some experiments, re-
combinant murine TNF-
 
 
 
 (R&D Systems) was injected intra-
scrotally at a dose of 500 ng per mouse in a volume of 0.3 ml of
sterile normal saline more than 4 h before the intravital micros-
copy experiment was started.
 
Transfer of PSGL-1
 
 
 
/
 
 
 
 Bone Marrow into Wild-Type Mice.
 
Approximately 2 
 
 
 
 10
 
6
 
 unfractionated bone marrow cells from
femora and tibiae of PSGL-1
 
 
 
/
 
 
 
 mice were injected into lethally
irradiated wild-type littermates (2 doses of 600 rad each 4 h apart)
via tail vein as described (26). After bone marrow transplantation,
recipient mice were transferred back to individually ventilated
cages with high-efficiency particulate air filters and received au-
toclaved water containing 5 mM sulfamethoxazole and 0.86 mM
trimethoprim (Sigma-Aldrich). Recipient mice were used for ex-
periments more than 4 wk after bone marrow reconstitution
when white blood cell counts had fully recovered.
 
Flow Cytometry.
 
Flow cytometry was used to detect PSGL-1
expression on peripheral blood leukocytes and platelets of wild-
type mice, PSGL-1–deficient mice, and lethally irradiated wild-
 
*
 
Abbreviations used in this paper:
 
 HUVEC, human umbilical vein endothe-
lial cell; PSGL, P-selectin glycoprotein ligand-1.T
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type mice transplanted with bone marrow from PSGL-1–defi-
cient mice. In addition, L-selectin expression on leukocytes of
PSGL-1–deficient mice was investigated. Whole blood was cen-
trifuged and red blood cells were lysed with PharM-Lyse-10X so-
lution (BD Biosciences), blood cells were suspended in PBS-1%
BSA (Sigma-Aldrich) solution and incubated for 30 min on ice
(0.5 
 
 
 
g/10
 
6
 
 cells) in the dark with the anti PSGL-1 mAb 2PH-1
conjugated with PE to detect leukocyte- or platelet-expressed
PSGL-1 or anti–L-selectin mAb MEL-14 conjugated with PE to
detect leukocyte-expressed L-selectin. As a negative control, iso-
type matched control antibodies conjugated with PE were used
(all BD Biosciences). After incubation, cells were washed twice in
PBS-1% BSA and analyzed by flow cytometry. For platelet flow
cytometry, whole carotid blood was centrifuged at 280 
 
g
 
 for 8
min at room temperature. The plasma layer and upper portion of
the cellular layer were removed and recentrifuged at 280 
 
g
 
 for 3
min. Platelets from the platelet-rich plasma layer were then
counted using a Hemavet 850 (CDC Technologies), divided into
samples of 5 
 
 
 
 10
 
6
 
 cells, and stained for 30 min at 4
 
 
 
C with opti-
mal staining concentrations of PE rat anti–mouse PSGL-1 (2PH1)
or rat IgG2a, FITC rat anti–mouse CD41 (MWReg30), and
APC rat anti–mouse GR-1 (RB6–8C5) or MAC-1 (M1/70) an-
tibodies (BD Biosciences). Samples were centrifuged at 600 
 
g
 
 for
15 min at room temperature and washed twice before analysis.
(FACScan™ with CELLQuest™ software package; Becton
Dickinson).
 
Intravital Microscopy.
 
Mice were anesthetized (20) and pre-
pared for intravital microscopy (27) as described. Venular diame-
ter, venular vessel segment length, and leukocyte rolling velocity
were measured using two digital image processing systems (28,
29). Venular centerline red blood cell velocity in the cremaster
muscle preparation was measured using a dual photodiode and a
digital on-line cross-correlation program (Circusoft Instrumenta-
tion), converted to mean blood flow velocity (30) and wall shear
rate (31) and used to calculate rolling leukocyte flux fraction.
Frame-to-frame video-analysis of image sequences obtained
during intravital experiments was used to assess interactions of
rolling leukocytes with the vessel wall. Leukocyte–leukocyte in-
teractions were defined as free flowing leukocytes interacting
with already adherent or rolling leukocytes. Leukocyte–leukocyte
interactions were also assumed for free flowing leukocytes when
interactions were observed in close proximity (
 
 
 
5 
 
 
 
m) to the ad-
herent leukocyte.
 
Immunohistochemistry.
 
Wild-type mice were prepared for in-
travital microscopy as described above. More than 1 h after sur-
gery, the P-selectin blocking mAb RB40.34 was injected and
L-selectin–mediated rolling observed. The entire cremaster was
then fixed in 4% paraformaldehyde overnight and transferred
into 70% ethanol the next day, dehydrated through graded alco-
hol and xylene and embedded in paraffin. 4 
 
 
 
m tissue sections
were deparaffinized, endogenous peroxidase activity was inacti-
vated with 0.3% hydrogen peroxide, and sections were then
washed in PBS with blocking solution (10% goat serum in PBS)
for 20 min, washed, and incubated overnight at 4
 
 
 
C with anti–
PSGL-1 mAb 4RA10, diluted 1:30. After washing, sections
were incubated with a secondary isotype matched goat anti–rat
IgG for 10 min, washed and incubated for 30 min with ABC re-
agent, containing a preformed avidin and biotinylated horserad-
ish peroxidase macromolecular complex (Vectastain; Vector
Laboratories). After washing, sections were placed in diami-
nobenzidine/hydrogen peroxide solution (DAB Peroxidase Sub-
strate Kit; Vector Laboratories), counterstained with hematoxy-
lin, 0.5% cupric acid and 1% lithium carbonate. After
dehydration, sections were enclosed in a xylene-based mounting
medium (Cytoseal XYL; Stephens Scientific) for microscopic
analysis, using an oil immersion objective (FLUAR Oil 100/1.3
numerical aperture).
 
Statistics.
 
Sigma Stat 2.0 (SPSS Science) was used for statisti-
cal analysis. Leukocyte counts, vessel diameters, leukocyte rolling
flux fractions, shear rates, and leukocyte rolling velocities be-
tween groups and treatments were compared with one-way
ANOVA followed by a multiple pairwise comparison test
(Dunn’s test) or by Wilcoxon rank-sum test, as appropriate. Sta-
tistical significance was set at P
 
 
 
  
 
0.05, indicated by 
 
*
 
.
 
Online Supplemental Material.
 
Flow cytometry results for
PSGL-1 expression on platelets, frame-by-frame analysis of leu-
kocyte rolling, and a video are available at http://www.jem.org/
cgi/content/full/jem.20021854/DC1.
 
Results
 
L-selectin–mediated Rolling in Venules with Trauma-induced
Inflammation.
 
We compared leukocyte rolling in 80
venules of seven PSGL-1
 
 
 
/
 
 
 
 mice with rolling in 70
venules of nine littermate controls. Vessel diameter, blood
flow velocity, and wall shear rate showed no significant dif-
ference among the groups (Table I). Leukocyte rolling in
untreated venules is initially P-selectin–dependent (8, 32),
followed by a second phase beginning 1 h after exterioriza-
tion which is both L-selectin and P-selectin–dependent (8,
33). To investigate L-selectin–dependent rolling, the P-selec-
tin blocking mAb RB40.34 was injected into wild-type
mice and leukocyte rolling flux assessed at more than 60
min after exteriorization. This led to a considerable de-
crease in rolling flux fraction from 27 to 5% at more than
1 h after exteriorization (Fig. 1 A). The residual rolling was
almost entirely dependent on L-selectin, because rolling
was blocked by injection of the L-selectin blocking anti-
body F(ab
 
 
 
)
 
2
 
 MEL-14 (Fig. 1 A). L-selectin-dependent
rolling is not equally distributed throughout the venular
tree but observed only in some postcapillary venules which
were used for analysis. Analysis of the recorded videotapes
did not show any evidence of accumulated platelets in
postcapillary cremaster muscle venules of wild-type mice
where L-selectin–mediated rolling was observed.
Consistent with a previous report (34), the leukocyte
rolling flux fraction in PSGL-1
 
 
 
/
 
 
 
 mice during the first
hour after surgery was much lower than in wild-type mice
(Fig. 1 A). Injection of the P-selectin blocking mAb
RB40.34 more than one hour after surgery eliminated leu-
kocyte rolling in PSGL-1
 
 
 
/
 
 
 
 mice. To further investigate
the role of PSGL-1 as L-selectin ligand we injected the
PSGL-1 blocking mAb 4RA10 into wild-type mice in
which P-selectin had been blocked and found an almost
complete loss of L-selectin–dependent leukocyte rolling
(Fig. 1 A). These results demonstrate that PSGL-1 is re-
quired for L-selectin–dependent rolling in trauma-induced
inflammation. The reduced L-selectin–mediated rolling in
PSGL-1–deficient mice was not due to low expression of
leukocyte L-selectin, because flow cytometry revealed
equal expression of L-selectin on both wild-type and
PSGL-1–deficient leukocytes (21).T
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L-selectin–mediated Rolling in TNF-
 
 
 
–induced Inflamma-
tion.
 
Intrascrotal injection of TNF-
 
 
 
 induces the expres-
sion of E-selectin and augments expression of P-selectin
(35). Four or more hours after TNF-
 
 
 
 injection, significant
L-selectin–mediated rolling can be observed (9). We inves-
tigated L-selectin–dependent rolling in 37 venules of four
(4–6 h) TNF-
 
 
 
 treated PSGL-1
 
 
 
/
 
 
 
 mice and compared it
to rolling in 54 venules of four TNF-
 
 
 
–treated littermate
control mice. Vessel diameter, blood flow velocity, and wall
shear rate of the different treatment groups were similar (Ta-
ble I). Consistent with previous studies, leukocyte counts
were reduced in both PSGL-1–deficient mice and wild-type
mice due to prolonged treatment with TNF-
 
 
 
 (Table I).
Injection of anti–P-selectin mAb RB40.34 and anti–E-
selectin mAb 9A9 into TNF-
 
 
 
 treated wild-type mice more
 
than 4 h after TNF-
 
 
 
 injection led to a significant drop in
leukocyte rolling flux fraction from 13 to 6% (Fig. 1 B). The
residual rolling was L-selectin–dependent as it could be
blocked with the additional injection of the anti-L-selectin
F(ab
 
 
 
)
 
2
 
 MEL-14 (Fig. 1 B). By contrast, no leukocyte rolling
was seen after injecting anti–P-selectin mAb RB40.34 and
anti–E-selectin mAb 9A9 into (4–6 h) TNF-
 
 
 
 treated
PSGL-1
 
 
 
/
 
 
 
 mice (Fig. 1 B), showing that L-selectin–medi-
ated rolling is also PSGL-1 dependent in this model.
 
L-selectin–dependent Rolling in Inflamed Venules Is Mediated
by PSGL-1 Derived from Bone Marrow–derived Cells.
 
To
address the question whether L-selectin–dependent rolling
is mediated by a yet unidentified expression of PSGL-1 on
endothelial cells, we conducted immunohistochemistry of
the cremaster muscle one hour after surgery using the
 
Table I.
 
Hemodynamic and Microvascular Parameters in Trauma- and TNF-
 
 
 
–induced Inflammation
 
Mouse genotype Mice Venules Diameter Centerline velocity
Wall shear
rate
Systemic
leukocyte counts
 
nn
 
 
 
m
 
 
 
m/s s
 
 
 
1
 
cells/
 
 
 
l
 
Trauma
PSGL-1
 
 
 
/
 
 
 
7 80 31   1 2,900   300 900   300 8,600   900*
Wild-type 9 70 32   1 2,900   300 1,000   100 5,800   500*
Chimera 3 37 32   3 3,200   700 1,000   200 7,200   300
TNF- 
PSGL-1 /  4 37 29   2 1,800   200 690   110 3,000   300
Wild-type 4 54 29   1 1,800   100 630   50 2,200   200
Chimera 2 16 31   1 1,900   200 700   80 5,300   600
Diameter, centerline velocity, and wall shear rate are presented as mean   SEM of all investigated venules. Significant difference (P   0.05) in
systemic leukocyte counts is indicated by *.
Figure 1. Leukocyte rolling
flux fraction (mean   SEM) in
(A) untreated cremaster muscle
venules of PSGL-1 deficient mice
(black bars, n   7) and wild-type
mice (gray bars, n   9), (C) in
4–6 h TNF-  treated cremaster
muscle venules of PSGL-1–defi-
cient (n   4) and wild-type mice
(n   4), or in (B) untreated or
(D) TNF- –treated wild-type
mice reconstituted with bone
marrow from PSGL-1–deficient
mice (black bars, n   3 and n  
2, respectively). anti-P, P-selectin
blocking mAb RB40.34; anti-
PSGL-1, PSGL-1 blocking mAb
4RA10; anti-L, L-selectin block-
ing F(ab )2 of mAb MEL-14,
anti-E, E-selectin blocking mAb
9A9.  1 h means within 1 h of
exteriorization, all other data at
 1 h after exteriorization. Signif-
icant differences (P    0.05) in
leukocyte rolling flux fraction be-
tween PSGL-1 /  and wild-type
group are indicated by *.T
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PSGL-1 mAb 4RA10. We could not detect any expression
of PSGL-1 on venular endothelium throughout the cre-
master muscle (unpublished data). To formally demonstrate
the importance of PSGL-1 expressed on bone marrow–
derived cells, we transferred PSGL-1 /  bone marrow cells
into lethally irradiated control littermates (n   3). Leuko-
cytes of chimeric mice failed to stain with phycoerythrin-
labeled anti–PSGL-1 mAb 2PH-1 using flow cytometry
(unpublished data). Hemodynamic parameters and leuko-
cyte counts in chimeric mice during intravital experiments
were similar compared with PSGL-1 /  mice and wild-
type mice (Table I). L-selectin–dependent leukocyte roll-
ing was assessed more than 1 h after surgery and after injec-
tion of P-selectin blocking mAb RB40.34. As shown in
Fig. 1 C, L-selectin–dependent rolling was sharply reduced
in the chimeric mice, which demonstrates that PSGL-1 ex-
pressed on bone marrow–derived cells mediates L-selectin–
dependent rolling in this model. Similar results were ob-
tained in cremaster venules of bone marrow–transplanted
mice treated with TNF-  for 4 h (Fig. 1 D), ruling out the
possibility that TNF-  treatment induces functionally sig-
nificant amounts of PSGL-1 in endothelial cells. Since in
one study (23) PSGL-1 expression has also been reported
on platelets, we measured PSGL-1 by flow cytometry and
found that PSGL-1 was not detectable on CD41  blood
platelets (online supplemental Fig. S1).
P-selectin–dependent Rolling Facilitates L-selectin–mediated
Rolling in Trauma-induced Inflammation. As demonstrated
above, leukocyte-expressed PSGL-1 mediates L-selectin–
dependent rolling in inflamed cremaster muscle venules.
This led us to hypothesize that leukocyte–endothelial inter-
actions mediated via P-selectin during early time-points
(within the first hour after exteriorization of the cremaster
muscle) may help to deliver leukocytes and possibly leuko-
cyte fragments to the venular wall that support L-selectin–
mediated rolling more than 1 h after surgery. To test this,
we pretreated wild-type mice with the P-selectin blocking
mAb Rb40.34 1 h before surgery aiming to block leukocyte
rolling completely during the first hour after exteriorization
of the cremaster muscle and hence prevent most leukocytes
from interacting with the venular endothelium. Untreated
mice were not included in our analysis, because we wished
to focus on the L-selectin–dependent portion of leukocyte
rolling. As shown in Fig. 2 A, L-selectin–dependent leuko-
cyte rolling was dramatically reduced to 1% when P-selectin
was blocked before surgery. This contrasts with a rolling
flux fraction of 5% when P-selectin was blocked acutely
during intravital microscopy. No statistically significant ef-
fect was seen after blocking CD18 before surgery (Fig. 2 A),
suggesting that leukocyte rolling through P-selectin is re-
quired to support L-selectin–dependent rolling later, and
that leukocyte adhesion is not prominent in this model.
L-selectin–dependent rolling was also reduced in TNF- –
treated mice when rolling was inhibited by blocking E- and
P-selectin or when firm adhesion was inhibited by blocking
CD18 integrins before injection of TNF-  (Fig. 2 B), sug-
gesting that both rolling and firmly adherent leukocytes
contribute to later L-selectin–dependent rolling.
Leukocyte Rolling Velocities for L-Selectin–dependent Roll-
ing. Leukocyte rolling velocities were measured more
than 1 h after surgery and after injection of P-selectin
blocking mAb RB40.34 (Fig. 3 A). This rolling was L-selec-
tin dependent, because it was completely abolished by in-
jecting F(ab) 2 fragments of MEL-14. In wild-type mice,
leukocyte rolling velocities (n   127) distributed broadly
with an average rolling velocity of 64   4  m/s (Fig. 3 A).
This is consistent with an earlier report on L-selectin–depen-
dent rolling velocities (33). In PSGL-1–deficient mice,
L-selectin–dependent rolling was abolished so that leuko-
cyte rolling velocities of only 11 leukocytes could be mea-
sured, which averaged 40   13  m/s (Fig. 3 B). This roll-
ing was blocked by injection of mAb 9A9 to E-selectin.
Analysis of E-selectin–dependent leukocyte rolling veloci-
ties in wild-type mice treated with blocking antibodies
against P-selectin (RB40.34) and against L-selectin (F(ab )2
MEL-14) revealed a similar rolling velocity in the few roll-
ing cells left (23   5  m/s, n   15; Fig. 3 C).
Leukocyte–Leukocyte Interactions Account for Most of the
L-Selectin–dependent Rolling in Inflamed Postcapillary Venules.
To investigate whether leukocyte–leukocyte interactions
contribute to L-selectin–dependent rolling, frame-to-frame
Figure 2. L-selectin–dependent leukocyte rolling flux fraction (mean  
SEM) at  60 min after exteriorization of (A) the untreated (trauma) or (B)
TNF- –treated cremaster muscle in wild-type mice in which P-selectin
(anti-P, black bars, n   3), both P- and E-selectin (anti-P/E, black bars,
n   4) or CD18 (dark gray bars, n   3 for trauma, n   2 for TNF- ) was
blocked before exteriorization of the cremaster muscle (pretreated). For
comparison, L-selectin–dependent rolling in both models is shown (light
gray bars, data from Fig. 1). Significant differences between different pre-
treatments (P   0.05) indicated by *. To demonstrate that rolling is L-selec-
tin–dependent in all cases, anti-L, L-selectin blocking F(ab )2 of mAb
MEL-14 was added (lower group of bars in each panel), resulting in sig-
nificantly reduced rolling flux fractions (indicated by #) compared with
mice in which only P-selectin (A) or P- and E-selectin were blocked (B).T
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video-analysis of leukocyte rolling was conducted under
conditions where rolling is mostly dependent on L-selectin
in wild-type mice. A total of 127 leukocytes were investi-
gated in wild-type mice. Most of the rolling leukocytes
(85%) interacted near already adherent leukocytes. In some
cases, interactions were initiated in the absence of visible
leukocyte–leukocyte interactions, suggesting that leukocyte
fragments deposited on the surface of endothelial cells may
be responsible for initiating leukocyte rolling. Scanning
electron microscopy of microvessels failed to reveal a clear
picture of leukocyte fragments as initiating events (unpub-
lished data). However, in support of the idea that such frag-
ments may be generated during rolling, we found that sev-
eral micrometer-long tethers were pulled from some
rolling cells (Fig. 4). Although we did not directly observe
these tethers detach from the leukocyte, such a mechanism
is plausible based on in vitro experiments (36) conducted
under conditions of superior optical resolution not achiev-
able by intravital microscopy.
Frame-to-frame video-analysis revealed intermittent leu-
kocyte interaction while moving from one adherent leuko-
cyte to the next (supplemental Fig. S2, A and B). In some
instances, leukocyte–leukocyte interactions were followed
by direct contact of the rolling leukocyte with the endo-
thelium, followed by a dramatic decrease in rolling veloc-
ity. Leukocyte rolling in wild-type mice treated with
blocking mAbs against P- and L-selectin also showed rare,
E-selectin–dependent leukocyte–endothelial interactions
(supplemental Fig. S2 C), while leukocyte–leukocyte inter-
actions were absent.
Discussion
This study identifies PSGL-1 as the L-selectin ligand re-
sponsible for L-selectin–dependent leukocyte rolling in in-
flamed venules of the cremaster muscle. We show that
L-selectin–mediated rolling is absent in PSGL-1 /  mice,
in mice where PSGL-1 is blocked by mAb 4RA10, or in
mice transplanted with PSGL-1 /  bone marrow, thus
providing evidence that PSGL-1 expressed by leukocytes
functions as the L-selectin ligand in inflamed postcapillary
venules. L-selectin ligand activity in inflamed postcapillary
venules is of physiological relevance and is responsible for
significant leukocyte accumulation in mice deficient in E-
and P-selectin (9).
In most cases, L-selectin–dependent rolling occurred on
already adherent leukocytes as a continuous series of sec-
ondary tethering or capture events. Individual secondary
tethering events have been observed in vitro (11, 12, 15)
and in vivo (14). Here, we demonstrate that series of such
tethering events support L-selectin–dependent rolling. In
addition, these tethering events can initiate rolling on E-selec-
tin, similar to what was previously demonstrated in vitro
Figure 3. Leukocyte rolling velocity distribution in untreated cremas-
ter muscle venules of (A) wild-type mice treated with P-selectin blocking
mAb RB40.34 (anti-P), (B) PSGL-1 /  mice treated with anti-P, and
(C) wild-type mice treated with anti-P and anti-L (L-selectin blocking
F(ab )2 of mAb MEL-14)  60 min after exteriorization. Rolling was
completely blocked by adding L- and E-selectin mAb in panel A, or E-selec-
tin mAb in panels B and C. Absolute cell numbers are shown for leuko-
cyte velocity groups with bin sizes of 10  m/s.
Figure 4. Some leukocytes rolling slowly along the endothelium (A)
showed transient adhesion, during which time (here, 13 s) they pulled
visible tethers of considerable length (B, arrow). Scale bar 5  m.
Supplemental video clip at http://www.jem.org/cgi/content/full/
jem.20021854/DC1.T
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(12). In a minority of cases, L-selectin and PSGL-1–depen-
dent rolling was seen without an obvious adherent leuko-
cyte being present. At least three possible mechanisms may
explain how PSGL-1 mediates L-selectin–dependent roll-
ing in these cases: (a) PSGL-1 is deposited on inflamed
venular endothelium on the surface of residual leukocyte
tethers left behind by rolling leukocytes (36). (b) PSGL-1 is
presented to free flowing leukocytes on the surface of leu-
kocyte-derived microparticles bound to the endothelium.
(c) Free flowing or rolling leukocytes interact with the uro-
pods of partially transmigrated leukocytes. Schmidtke et al.
conducted experiments using an in vitro flow chamber sys-
tem where neutrophils were perfused over a layer of im-
mobilized platelets (36). The results demonstrated that roll-
ing leukocytes form membrane tethers of different length
while rolling over the immobilized platelet layer. In some
instances, these membrane tethers were dislodged from the
leukocyte and remained attached to the platelet layer. The
authors suggested that the endothelium-deposited leuko-
cyte tethers may facilitate leukocyte capture to the endo-
thelium which may be followed by rolling along the endo-
thelium (36). We found evidence of tether formation on
rolling leukocytes under in vivo conditions. It is possible
that these tethers detach from the rolling leukocyte and re-
main bound to the endothelium, where they may present
PSGL-1 to promote L-selectin–dependent capture and
rolling events.
In cases where leukocyte–leukocyte interactions cannot
be demonstrated to be responsible for L-selectin dependent
rolling, the uropods of transmigrating cells may also pro-
vide a rich source of PSGL-1. Activation of neutrophils in-
duces redistribution of PSGL-1 to the uropods of polarized
(37) and migrating neutrophils (38). This is a very attrac-
tive possibility, suggesting that PSGL-1 redistribution dur-
ing transmigration may initiate L-selectin–dependent in-
teractions. Further investigations will be required to
positively identify neutrophil tethers, microparticles, or
uropods that support L-selectin– and PSGL-1–dependent
rolling in vivo.
Two previous studies investigated the role of leukocyte–
leukocyte interactions for leukocyte recruitment during in-
flammation in vivo (13, 14). Kunkel et al. observed leuko-
cyte rolling and adhesion in (1–2.5 h) TNF-  stimulated
cremaster muscle venules and found that leukocyte accu-
mulation occurs in clusters whose formation was depen-
dent on the expression of E-selectin (13). Leukocytes re-
cruited into these clusters entered the cluster in the
majority of cases while already rolling along the endothe-
lium. The contribution of free flowing leukocytes entering
the cluster by leukocyte–leukocyte interactions was very
low (1% of the total number of recruited leukocytes; refer-
ence 13). Eriksson et al. (14) demonstrated that secondary
capture or tethering events were responsible for a signifi-
cant fraction of newly initiated leukocyte rolling events, es-
pecially in larger venules. Secondary capture accounted for
36% of all observed capture events during trauma-induced
rolling, and for 25% in TNF-  and IL-1 –induced rolling.
All secondary capture was L-selectin–dependent, but the
role of PSGL-1 was not addressed in that study (14). The
present study demonstrates a requirement for PSGL-1 and
extends the previous findings to smaller venules with diam-
eters from 10 to 40  m.
L-selectin–dependent leukocyte rolling was not uni-
formly distributed, and most of the cremaster muscle
venules did not show any L-selectin–dependent rolling.
This may be due to a local variation in endothelial adhesion
molecule expression. The most likely candidate would be
E-selectin, as leukocyte–endothelial interactions observed
during L-selectin–dependent rolling were sensitive to treat-
ment with the E-selectin blocking mAb 9A9. Immunohis-
tological studies on the distribution of endothelial adhesion
molecules in the cremaster muscle microcirculation found a
patchy expression of E-selectin in the unstimulated cremas-
ter muscle vasculature (35), consistent with the functional
data presented here. This interpretation is also consistent
with the significant time delay seen between tissue prepara-
tion and the onset of L-selectin–dependent rolling. Most
likely, L-selectin–dependent rolling can occur only in areas
where E-selectin expression has resulted in sufficient accu-
mulation of rolling and adherent leukocytes and leukocyte
fragments to provide PSGL-1 as a substrate for rolling.
A previous study found that both mouse and human
platelets express PSGL-1 (23). In that study, a polyclonal
antibody to mouse PSGL-1 bound to 20% of platelets,
while preimmune serum bound to only 5%. PSGL-1 was
also demonstrated by Western blot in platelet preparations,
but platelet preparations can contain contaminating leuko-
cytes and leukocyte fragments. Indeed, some CD14 stain-
ing (a monocyte marker) and some CD11b staining (a neu-
trophil and monocyte marker) was detected in the previous
study (23). In platelet preparations free of leukocyte frag-
ments, we were unable to confirm any significant PSGL-1
expression on mouse platelets.
The finding that all L-selectin–dependent leukocyte roll-
ing in cremaster venules requires PSGL-1 also explains the
recent finding that L-selectin–mediated rolling in inflamed
cremaster venules, but not in secondary lymphatic organs
like Peyer’s patches, requires posttranslational modifica-
tion by core2 N-acetylglucosaminyl transferase (core2
GlcNAcT; reference 20). In light of the present findings,
this core2 GlcNAcT requirement is most likely related to
PSGL-1 requiring the core2 modification in order to func-
tion as an L-selectin ligand. Conversely, L-selectin medi-
ates rolling in secondary lymphatic organs by binding to
different, core2 GlcNAcT- and PSGL-1-independent
ligands including those defined by reactivity with MECA-
79 mAb (5).
L-selectin–dependent capture and rolling events on
PSGL-1–expressing leukocytes and leukocyte fragments
not only amplify the recruitment of neutrophils to sites of
inflammation, but may also be able to initiate binding of
other L-selectin–expressing cells that do not express
ligands for endothelial P- and E-selectin. This mechanism
would lead to representation of a broader range of white
blood cells recruited during the course of inflammation. A
recent study (39) reported a significant defect of CD8  TT
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cell recruitment to the inflamed skin in a model of de-
layed-type hypersensitivity. In this model, injection of the
L-selectin blocking antibody Mel-14 (intact IgG2a) re-
duced recruitment of CD8  T cells to the inflamed skin in
E- and P-selectin double-deficient mice. In these mice,
CD8  T cell recruitment was independent of PSGL-1 ex-
pression on CD8  T cells. However, in this model, neu-
trophils or other inflammatory cells derived from the re-
cipient mice may be present in microvessels of inflamed
skin and may provide PSGL-1 that could support L-selec-
tin–dependent recruitment of CD8  T cells through the
mechanism described here.
Our study demonstrates that L-selectin–mediated rolling
in inflamed venules in vivo is entirely dependent on PSGL-1
expressed on bone marrow–derived cells. Leukocyte–endo-
thelial interactions following these secondary tethering
events require E-selectin. Our findings reconcile previous
observations of a pronounced defect in inflammatory cell
recruitment in L-selectin /  mice (7–9) or in mice in
which L-selectin function was blocked (6, 9, 39) with the
failure to find expression of functionally relevant L-selectin
ligands on inflamed endothelial cells.
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